{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:56:24Z","timestamp":1778914584188,"version":"3.51.4"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/rlu.0000000000000728","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T11:22:48Z","timestamp":1423740168000},"page":"521-522","source":"Crossref","is-referenced-by-count":4,"title":["18fF-FDG PET\/CT for Detection of Leukemic Transformation in Myelofibrosis"],"prefix":"10.1097","volume":"40","author":[{"given":"Thorsten","family":"Derlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till Sebastian","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210204","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1200\/JCO.2004.00.9316","article-title":"Pathogenesis of myelofibrosis with myeloid metaplasia.","volume":"23","author":"Tefferi","year":"2005","journal-title":"J Clin Oncol"},{"key":"R2-18-20210204","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.leu.2405080","article-title":"Choosing between stem cell therapy and drugs in myelofibrosis.","volume":"22","author":"Kroger","year":"2008","journal-title":"Leukemia"},{"key":"R3-18-20210204","first-page":"214","article-title":"Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis.","volume":"37","author":"Hasselbalch","year":"2013","journal-title":"A human inflammation model for cancer development Leuk Res"},{"key":"R4-18-20210204","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2141.1990.tb02609.x","article-title":"Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.","volume":"75","author":"Visani","year":"1990","journal-title":"Br J Haematol"},{"key":"R5-18-20210204","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF02981937","article-title":"Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients.","volume":"73","author":"Okamura","year":"2001","journal-title":"Int J Hematol"},{"key":"R6-18-20210204","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood-2004-07-2864","article-title":"Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.","volume":"105","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"R7-18-20210204","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1440-1827.2012.02813.x","article-title":"Autopsy case of primary myelofibrosis in which myeloid sarcoma was the initial manifestation of tumor progression.","volume":"62","author":"Morita","year":"2012","journal-title":"Pathol Int"},{"key":"R8-18-20210204","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/RLU.0b013e31825b2071","article-title":"FDG PET or PETCT for detecting intramedullary and extramedullary lesions in multiple Myeloma: a systematic review and meta-analysis.","volume":"37","author":"Lu","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R9-18-20210204","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(11)61940-5","article-title":"Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkins lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.","volume":"379","author":"Engert","year":"2012","journal-title":"Lancet"},{"key":"R10-18-20210204","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/RLU.0b013e3182952976","article-title":"18F-FDG PET for diagnosis and response assessment for aggressive NK cell leukemia.","volume":"39","author":"Park","year":"2014","journal-title":"Clin Nucl Med"},{"key":"R11-18-20210204","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ejh.12085","article-title":"Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET.","volume":"90","author":"Cribe","year":"2013","journal-title":"Eur J Haematol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:11:11Z","timestamp":1620972671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201506000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000728","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}